Knowledge and Attitudes of Indonesian General Practitioners Towards the Isoniazid Preventive Therapy Program in Indonesia |
Winardi, Wira
(Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Syiah Kuala)
Nalapraya, Widhy Yudistira (Faculty of Medicine, Universitas Islam Bandung) Sarifuddin, Sarifuddin (Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Tadulako University) Anwar, Samsul (Department of Statistics, Faculty of Mathematics and Natural Sciences, Universitas Syiah Kuala) Yufika, Amanda (Department of Family Medicine, School of Medicine, Universitas Syiah Kuala) Wibowo, Adityo (Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Lampung) Fadhil, Iziddin (Faculty of Medicine, Universitas Abulyatama) Wahyuni MS, Hendra (Faculty of Medicine, Universitas Malikussaleh) Arliny, Yunita (Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Syiah Kuala) Yanifitri, Dewi Behtri (Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Syiah Kuala) Zulfikar, Teuku (Department of Pulmonology and Respiratory Medicine, School of Medicine, Universitas Syiah Kuala) Harapan, Harapan (Medical Research Unit, School of Medicine, Universitas Syiah Kuala) |
1 | Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, et al. Global tuberculosis report 2020 - reflections on the global tb burden, treatment and prevention efforts. Int J Infect Dis 2021;113(Suppl 1):S7-S12. DOI |
2 | Zumla A, Nahid P, Cole ST. Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discov 2013;12(5):388-404. DOI |
3 | GBD Tuberculosis Collaborators. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. Lancet Infect Dis 2018;18(3):261-284. DOI |
4 | Chaudhary R, Bhatta S, Singh A, Pradhan M, Shrivastava B, Singh YI, et al. Diagnostic performance of GeneXpert MTB/RIF assay compared to conventional Mycobacterium tuberculosis culture for diagnosis of pulmonary and extrapulmonary tuberculosis, Nepal. Narra J 2021;1(2):e33. |
5 | Uplekar M, Raviglione M. WHO's End TB Strategy: from stopping to ending the global TB epidemic. Indian J Tuberc 2015;62(4):196-199. DOI |
6 | MacNeil A, Glaziou P, Sismanidis C, Date A, Maloney S, Floyd K. Global epidemiology of tuberculosis and progress toward meeting global targets - worldwide, 2018. MMWR Morb Mortal Wkly Rep 2020;69(11):281-285. |
7 | Burke RM, Nliwasa M, Feasey HR, Chaisson LH, Golub JE, Naufal F, et al. Community-based active case-finding interventions for tuberculosis: a systematic review. Lancet Public Health 2021;6(5):e283-e299. DOI |
8 | Jeremiah C, Petersen E, Nantanda R, Mungai BN, Migliori GB, Amanullah F, et al. The WHO global tuberculosis 2021 report - not so good news and turning the tide back to End TB. Int J Infect Dis 2022:S1201-9712(22)00149-7. |
9 | Ayele HT, Mourik MS, Debray TP, Bonten MJ. Isoniazid prophylactic therapy for the prevention of tuberculosis in HIV infected adults: a systematic review and meta-analysis of randomized trials. PLoS One 2015;10(11):e0142290. DOI |
10 | Houben RM, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med 2016;13(10):e1002152. DOI |
11 | Mandal S, Bhatia V, Sharma M, Mandal PP, Arinaminpathy N. The potential impact of preventive therapy against tuberculosis in the WHO South-East Asian Region: a modelling approach. BMC Med 2020;18(1):163. DOI |
12 | Abdulrazaak AT, Govender I, Nzaumvila D. Knowledge, attitudes and practices of doctors regarding isoniazid preventive therapy in HIV/AIDS patients at Odi District Hospital, Gauteng province, South Africa. S Afr J Infect Dis 2018;33(5):1-11. |
13 | Huang CC, Becerra MC, Calderon R, Contreras C, Galea J, Grandjean L, et al. Isoniazid preventive therapy in contacts of multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2020; 202(8):1159-1168. DOI |
14 | Collins D, Hafidz F, Mustikawati D. The economic burden of tuberculosis in Indonesia. Int J Tuberc Lung Dis 2017;21(9):1041-1048. DOI |
15 | Reviono R, Setianingsih W, Damayanti KE, Ekasari R. The dynamic of tuberculosis case finding in the era of the public-private mix strategy for tuberculosis control in Central Java, Indonesia. Glob Health Action 2017;10(1):1353777. DOI |
16 | Suryanto, Plummer V, Boyle M. Healthcare system in Indonesia. Hosp Top 2017;95(4):82-89. DOI |
17 | van Halsema CL, Fielding KL, Chihota VN, Russell EC, Lewis JJ, Churchyard GJ, et al. Tuberculosis outcomes and drug susceptibility in individuals exposed to isoniazid preventive therapy in a high HIV prevalence setting. AIDS 2010;24(7):1051-1055. DOI |
18 | Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev 2000;1999(2):CD001363. |
19 | Ross JM, Badje A, Rangaka MX, Walker AS, Shapiro AE, Thomas KK, et al. Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data. Lancet HIV 2021;8(1):e8-e15. DOI |
20 | Ayele HT, van Mourik MS, Bonten MJ. Predictors of adherence to isoniazid preventive therapy in people living with HIV in Ethiopia. Int J Tuberc Lung Dis 2016;20(10):1342-1347. DOI |
21 | Ministry of Health, Republic of Indonesia. Technical instructions for handling latent tuberculosis infection (ILTB); 2020 [cited 2022 May 1]. Available from: https://tbindonesia.or.id/wp-content/uploads/2021/01/Isi-Juknis-ILTB-FINAL-ok_published.pdf (Indonesian). |
22 | Ministry of Health, Republic of Indonesia. Regulation of the Minister of Health number 67 year 2016 on tuberculosis control [cited 2022 May 1]. Available from: http://hukor.kemkes.go.id/uploads/produk_hukum/PMK_No._67_ttg_Penanggulangan_Tuberkolosis_.pdf (Indonesian). |
23 | Mahendradhata Y, Lestari T, Probandari A, Indriarini LE, Burhan E, Mustikawati D, et al. How do private general practitioners manage tuberculosis cases? A survey in eight cities in Indonesia. BMC Res Notes 2015;8:564. DOI |
24 | Durovni B, Cavalcante SC, Saraceni V, Vellozo V, Israel G, King BS, et al. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. AIDS 2010;24(Suppl 5):S49-S56. |
25 | Surya A, Setyaningsih B, Suryani Nasution H, Gita Parwati C, Yuzwar YE, Osberg M, et al. Quality tuberculosis care in Indonesia: using patient pathway analysis to optimize public-private collaboration. J Infect Dis 2017;216(Suppl_7):S724-S732. DOI |
26 | Bateman C. Doctor IPT ignorance contributing to TB epidemic--study. S Afr Med J 2011;101(2):88, 90. |
27 | Martinson NA, Barnes GL, Moulton LH, Msandiwa R, Hausler H, Ram M, et al. New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med 2011;365(1):11-20. DOI |
28 | Teklay G, Teklu T, Legesse B, Tedla K, Klinkenberg E. Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study. BMC Public Health 2016;16(1):840. DOI |
![]() |